v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (10,137) $ (11,105)
Reconciliation of net loss to net cash used in operating activities:    
Share based compensation 714 599
Loss on settlement of common stock warrant liabilities 759 (0)
Change in fair value of warrant liabilities (157) (1,544)
Issuance of Stock for Licenses Acquired 0 1,230
Research and development-licenses acquired, expense 0 3,000
Issuance of common stock to Fortress 543 72
Common shares issuable - Founders Agreement (357) 0
Changes in operating assets and liabilities:    
Other receivables - related party 0 (13)
Prepaid expenses and other current assets 39 119
Deferred financing costs 0 (239)
Net cash used in operating activities (8,262) (7,127)
Cash flows from investing activities:    
Purchase of research and development licenses 0 (3,000)
Net cash used in investing activities 0 (3,000)
Cash flows from financing activities:    
Issuance of common stock and pre-funded warrants, net of offering costs - registered direct offering and private placement 0 3,101
Shares issued in a private placement offering 0 550
Deferred financing costs 0 (71)
Proceeds from ATM sales of common stock, net of issuance costs 862 0
Exercise of warrants 9,421 0
Warrant transaction costs (1,207) 0
Net cash provided by financing activities 9,076 3,580
Net change in cash and cash equivalents 814 (6,547)
Cash and cash equivalents, beginning of period 1,783 6,708
Cash and cash equivalents, end of period 2,597 161
Supplemental cash flow information:    
Unpaid financing costs 0 239
Issuance of common shares - Founders Agreement 543 0
Related Party [Member]    
Changes in operating assets and liabilities:    
Accounts payable and accrued expenses 140 511
Nonrelated Party [Member]    
Changes in operating assets and liabilities:    
Accounts payable and accrued expenses $ 194 $ 243

Source

PDF HTML 10-Q Filing
ZIP XLS HTML XBRL